RESEARCH AND DEVELOPMENT
Research and Development
A Phase I, Randomized, Single-Dose Study to Evaluate the Biosimilarity of HOT-3010 to Adalimumab Among Healthy Chinese Male Subjects
Original Research Article:
Frontiers in Pharmacology
https:// 10.3389/fphar.2021.646171